截至到2025年3月11日，由Sam S Yoon作为负责人的已经被撤回包括在MOLECULAR CANCER RESEARCH，Cancer Research，CLINICAL CANCER RESEARCH 及Cell Death & ...

Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...

ST316, a β-catenin/BCL9 antagonist, demonstrated safety, target engagement, and early antitumor activity in advanced solid tumors.

In recognition of their discovery of one of our immune system’s foundations, physician Andrea Ablasser, virologist Glen ...

Breast cancer is one of the leading causes of mortality among women worldwide. Tumor necrosis factor α-induced protein 3-interacting protein 1 (TNIP1) is a ubiquitin-binding protein that is widely ...

AUSTIN, TX & PHILADELPHIA, PA — Faeth Therapeutics and The GOG Foundation, Inc. have announced a significant milestone in the ...

Scientists found that aspirin blocks TXA2, freeing T cells to fight cancer. This discovery could help prevent metastasis, but ...

Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

A growing interest has emerged in natural compounds with potential therapeutic benefits, with ginger (Zingiber officinale) being a notable example ...

PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...